Novo Holdings invests in US$105 million Series C Funding of Alentis Therapeutics ...Middle East

Alentis Therapeutics is a clinical-stage biotech developing breakthrough treatments for organ fibrosis and Claudin-1 (CLDN1) positive tumors Funding to advance clinical development of two first-in-class anti-CLDN1 antibodies and the platform to engineer CLDN1 antibody drug conjugates...

Hence then, the article about novo holdings invests in us 105 million series c funding of alentis therapeutics was published today ( Thursday 13/04/2023 - 08:09 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Novo Holdings invests in US$105 million Series C Funding of Alentis Therapeutics )

Also on site :

• Deye 2026 Frankfurt Distributor & Partner Summit Concludes Successfully
• Iranians Fear Trump’s Threat to Strike Power Plants
• Crimson Desert patch 1.00.03 addresses storage issues, Keyboard & mouse controls & more